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Evidence that the genome is pervasively 
transcribed into hundreds of thousands 
different RNAs (1,2) necessitates methods 
for independent high-throughput verifi-
cation of transcriptional starting sites 
(TSSs) determined by genome-wide 
approaches. 5′-RACE PCR is a well-estab-
lished and widely used method to specif-
ically amplify the 5′ end of a transcript, 
facilitating mapping of the TSS and the 
approximate location of promoter elements 
(3). Conventionally, this mapping is done 
by cloning the 5′-RACE PCR product 
into a bacterial vector and sequencing a 
few clones by classic electrophoresis-based 
Sanger sequencing. A great challenge for 
transcriptional analysis in general is the 
recently recognized prevalence of mecha-
nisms that expand the potential transcript 
repertoire, such as alternative splicing, 
alternative promoter usage, and multiple 
TSSs (1,4). In order for a 5′-RACE PCR 
assay to reflect such diversity, sequencing 
a fairly large number of clones is necessary, 
and when more than one transcript is 
to be analyzed by 5′-RACE PCR this 
procedure becomes comprehensive and 
time-consuming, not to mention costly. 
To address this drawback, we developed 
a simple assay in which 5′-RACE PCR 
products are subjected directly to high-
throughput sequencing by the newly 
developed flow cell sequencing technol-
ogies (5) that are currently revolution-
izing DNA sequencing by enabling the 
sequencing of hundreds of millions bases 
in a single sequencing run. Based on clonal 
amplification of millions of single surface-
immobilized DNA fragments (6,7), flow 
cell sequencing technologies have been 
recognized for their aptness for ultra-high 
throughput approaches such as whole-
genome sequencing. However, since it 
eliminates the need for cloning steps 
and facilitates quantitative assessment 
of transcription, the high-throughput 
sequencing approach is also a very 
appealing option for single-gene analysis 
such as with 5′-RACE PCR.
To explore the possibility of combining 
5′-RACE PCR with high-throughput 
sequencing, we selected 17 genes or 
genomic loci displaying expression in 
Hep G2 cells (Catalog no. HB-8065, 
ATCC, Manassas, VA, USA) according 
to the ENcyclopedia of DNA Elements 
(ENCODE) Project (2) and cap-analysis 
gene expression (CAGE) data (1). The 
RNA ligase-mediated (RLM) RACE 
PCR approach (8,3) for specifically ampli-
fying the 5′ end of cDNA from full-length, 
capped transcripts was adapted to perform 
high-throughput 5′-end sequencing on 
total RNA extracted from HepG2 cells 
(Figure 1). Normally, flow cell sequencing 
requires a sample preparation step in which 
sequencing adapters are ligated to both 
ends of the DNA fragments. Omitting 
this step, the primers for the inner PCR 
were designed with ∼20-bp-long deriv-
atives of specific adapter sequences of 
the Illumina Genome Analyzer (Tokyo, 
Japan) attached to the 5′ ends (Figure 1). 
Following nested PCR, the inner 5′-RACE 
PCR reactions for all 17 genes were pooled 
and purified using a standard PCR purifi-
cation kit (QIAGEN, Tokyo, Japan), and 
the resulting mixture of PCR products 
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We present a high-throughput method for investigating the transcrip-
tional starting sites of genes of interest, which we named Deep-RACE 
(Deep−rapid amplification of cDNA ends). Taking advantage of the latest 
sequencing technology, it allows the parallel analysis of multiple genes and 
is free of time-consuming cloning steps. In comparison to the sequencing 
of RACE PCR products, our approach is more precise and more cost-ef-
fective even for batches as small as 17.
Figure 1. Schematic representation of the 5′-RACE 
PCR procedure optimized for the high-throughput 
Illumina Genome Analyzer. Total RNA from Hep 
G2 hepatocellular carcinoma cells was treated 
with calf intestine phosphatase (CIP) to remove 
free 5′ phosphates and with tobacco acid py-
rophosphatase (TAP) to detach the cap of full-
length transcripts, following the manufacturer’s 
instructions of the FirstChoice RLM-RACE Kit 
(Applied Biosystems, Tokyo, Japan). The 5′ 
RACE adapter included in the kit was ligated to 
decapped molecules, and reverse transcription 
with random decamers was performed. Outer 
PCR reactions were carried out using a com-
mon adapter-specific forward primer included 
in the kit and custom gene-specific reverse 
primers. For the inner nested PCR reactions, 
in which the outer PCR reactions were used as 
templates, a common adapter-specific forward 
primer with the sequence AATGATACGGCGAC-
CACCGAACACTGCGTTTGCTGGCTTTGATG was 
constructed (bold letters designate an Illumina-
specific adapter sequence). The gene-specific 
inner reverse primers were designed with an 
Illumina-specific adapter sequence, CAAGCA-
GAAGACGGCATACGA, attached to the 5′ end. 
The resulting PCR products, designed to be 
approximately 100–300 bp in length, were 
PCR-purified and subjected to high-through-
put sequencing-by-synthesis in an Illumina 
genome analyzer with a sequencing primer of 
sequence GACCACCGAACACTGCGTTTGCTG-
GCTTTGATG. Sequences were deposited in the 
NCBI Short Read Archive under accession no. 
SRA003626.
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was loaded in a single flow cell channel in 
the high-throughput sequencer Genome 
Analyzer. A total of 2,145,126 sequence 
reads were obtained and 1,280,189 of 
them could be mapped on 88,554 distinct 
TSSs of the human genome using the 
“nexalign” program as described by T. 
Lassmann et al. (manuscript in prepa-
ration). We used the Galaxy web service 
(galaxy.psu.edu; Reference 9) to identify 
the genomic intervals where most reads 
align. TSSs with a read count higher than 
500 were selected and clustered, and the 
clusters were then extended by 100 bp in 
the 5′ and 3′ directions. This yielded 26 
genomic intervals that we used to filter 
our original data and rescue TSSs with 
read counts lower than 500. Eighteen of 
the intervals corresponded to our loci of 
interest (one has two promoters), and the 
other corresponded to repeated regions of 
the genome. Each gene is covered by an 
average of more than 74,000 sequences. 
Even the gene with lowest coverage has 
3,195 tags, suggesting that up to a few 
hundreds of different, non-overlapping 
transcriptional starting sites or genes 
could be investigated with a good chance 
of success.
To compare this Deep-RACE assay 
with the classic 5′-RACE PCR procedure 
based on Sanger sequencing, 9 of the 17 
outer 5′-RACE PCR reactions were used 
as templates in inner 5′-RACE PCR 
reactions using primers without Illumina-
specific adapter sequences. The resulting 
PCR products were cloned in TOPO2.1 
vectors (Invitrogen), and 192 colonies 
(19–24 per gene) were picked and used as 
templates in PCR reactions using vector-
specific primers. Afterwards, the colony 
PCR products were subjected to capillary 
electrophoresis sequencing in an ABI 
3700 sequencer (Applied Biosystems, 
Tokyo, Japan). On average, 12 usable 
sequences per gene were obtained by 
the Sanger sequencing approach. The 
sequence reads were aligned to the genome 
Figure 2. Transcription start sites for four human transcribed regions analyzed by Deep-RACE, classical RACE-PCR, and cap analysis of gene expression 
(CAGE). The TSSs for H3 histone family member C (HIST1H3C) (A), staphylococcal nuclease domain containing 1 (SND1) (B), an unannotated transcript 
on chromosome 5 (C), and protein phosphatase 2A, regulatory subunit B′ (PPP2R4) (D) were deduced from a conventional Sanger sequencing−based 
5′-RACE PCR assay and from the high-throughput Illumina sequencing approach and compared with FANTOM3 CAGE library H22B (1). Each bar, depict-
ing the number of sequences starting at a certain position, corresponds to a TSS. The maximum number of sequences comprising a TSS is indicated at 
the left. The position respective to the RefSeq gene model is indicated as a blue bar. The absolute coordinates on the human chromosomes (NCBI build 
36.1) are indicated in the upper part of each panel. Note that in C, the bars are upside-down to reflect that transcription occurs on the minus strand.
A C
B D
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using the BLAT server of the University 
of California-Santa Cruz (UCSC) 
genome browser (genome.ucsc.edu; 
Reference 10). As expected, the positions 
of the main TSSs deduced from the two 
methods correspond well (Figure 2), and 
where a TSS flexibility can be observed, 
this is reflected in both assays (Figure 2, 
A and D). The average number of TSSs 
per gene is 5, according to the Sanger 
sequencing assay, while there are twice as 
many when the same genes are analyzed 
by high-throughput sequencing. Thus, 
although both methods appear to be 
suitable for qualitative assessment of 
TSSs, classic Sanger sequencing comprises 
risks of neglecting rarely used TSSs. Such 
rare TSSs have been discovered in the 
past using high-throughput methods 
like CAGE (1), and while their biological 
function is still mostly unexplored, they 
are valuable signals that can only be 
detected by deep sequencing. To assess 
the capacity of Deep-RACE to detect 
rare TSSs, we compared our results to the 
mapping of 811,195 CAGE tags from the 
HepG2 library H22B of the FANTOM3 
project (fantom.gsc.riken.jp; Reference 
1). CAGE libraries detect comparable 
amounts of TSSs, except in some cases 
where there is a global discrepancy of the 
results (Figure 2B). Qualitative differences 
between the three techniques compared 
here can be explained by the specificities 
of their methodologies. For instance, 
the CAGE library uses random priming, 
whereas 5′ RACE relies on a gene-specific 
primer, so the TSS of isoforms lacking 
sequences complementary to gene-specific 
primer will not be visible with RACE. 
Sequencing methods can also explain 
some discrepancies: while Deep-RACE 
does not depend on cloning, classical 
RACE methods contain some steps 
where the DNA has to be transfected in 
bacterial vectors. Sequences easier to clone 
can be favored, which would explain the 
occurrences of TSSs detected in classical 
RACE but not in the high-throughput 
CAGE and Deep-RACE methods.
In summary, we have shown that 
it is possible to combine transcrip-
tional analysis by 5′-RACE PCR with 
high-throughput sequencing, thereby 
dramatically increasing the quantity of 
sequence data compared with a conven-
tional 5′-RACE PCR assay while also 
saving considerable amounts of time and 
effort. By subjecting a mixture of RACE 
PCR products directly to sequencing 
in a second generation sequencer, an 
elaborate cloning procedure is omitted, 
and moreover, construction of primers 
with sequencing adapters removes the 
need for an overnight ligation step prior 
to sequencing. The simplicity of the 
method facilitates parallel TSS analysis of 
potentially hundreds of genes, and since 
millions of sequences are obtained in a 
single run, highly reliable assessments of 
TSS positions and relative usage should 
be gained even when a large number 
of genes are analyzed simultaneously. 
Finally, since the sequencing reaction 
occupies only a single f low cell channel 
regardless of the number of 5′-RACE 
PCR reactions, high-throughput 
sequencing of 5′-RACE PCR products 
is likely to be economical compared with 
Sanger sequencing. By sequencing only 
17 genes with Deep-RACE, the cost is 
equivalent with the Sanger method (in 
terms of reagents alone, and not taking 
into account the cost of labor), suggesting 
that high-throughput sequencing will be 
very cost-effective for large-scale TSS 
verification. In comparison to global 
approaches, such as whole transcriptome 
shotgun sequencing (11,12), Deep-RACE 
needs at least one order of magnitude less 
sequencing, produces tags only from 
templates that are full-length in 5′, and 
works directly on total RNA. Also, 
Deep-RACE results are easy to analyze 
with graphical tools such as Galaxy (9). 
Hence, we predict that the presented 
method will be the tool of choice for 
parallel TSS analysis of multiple genes.
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